Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-27 @ 6:00 AM
Study NCT ID:
NCT04979468
Status:
UNKNOWN
Last Update Posted:
2021-07-28
First Post:
2021-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)
Sponsor:
Societa' Italiana Di Malattie Infettive E Tropicali
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2019-004241-32
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None